Searched over 200M research papers
10 papers analyzed
These studies suggest that amlodipine is not an ACE inhibitor but can be effectively combined with ACE inhibitors for enhanced cardiovascular benefits.
19 papers analyzed
Amlodipine and angiotensin-converting enzyme (ACE) inhibitors are both used to manage cardiovascular conditions, but they belong to different classes of medications. Amlodipine is a calcium channel blocker, while ACE inhibitors, such as enalapril and ramipril, work by inhibiting the enzyme responsible for converting angiotensin I to angiotensin II, a potent vasoconstrictor.
Amlodipine functions by inhibiting the influx of calcium ions into vascular smooth muscle and cardiac muscle, leading to vasodilation and reduced blood pressure . On the other hand, ACE inhibitors reduce the production of angiotensin II, leading to vasodilation, decreased blood volume, and lower blood pressure .
Research has shown that combining amlodipine with ACE inhibitors can have synergistic effects, particularly in the regulation of myocardial oxygen consumption and nitric oxide production. Studies indicate that this combination can lead to more efficient blood pressure control and improved cardiovascular outcomes . For instance, the combination of amlodipine and ramiprilat has been shown to significantly reduce myocardial oxygen consumption more than either drug alone.
Clinical trials have demonstrated the benefits of combining amlodipine with ACE inhibitors in various cardiovascular conditions. For example, the combination therapy has been found to be more effective in reducing cardiovascular events compared to monotherapy with either drug . Additionally, this combination has been shown to improve nitric oxide production, which is beneficial for vascular health .
Amlodipine is not an ACE inhibitor; it is a calcium channel blocker. However, when used in combination with ACE inhibitors, it can provide enhanced therapeutic benefits for patients with cardiovascular conditions. This combination therapy leverages the complementary mechanisms of action of both drug classes, leading to improved outcomes in blood pressure management and cardiovascular health.
Most relevant research papers on this topic